BackViking Therapeutics Overview
Viking Therapeutics Inc

Viking Therapeutics Discounted Cash Flow

DCF Analysis for VKTX.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$1.47

Current Fair Value

$1.47
95.2% Downside

Overvalued by 95.2% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading